Patent Office Awards Patent Term Adjustment Based on Delay Related to a Vacated Office Action

Firm News, Patent

Meunier Carlin & Curfman client Oncolytics Biotech Inc. of Calgary, Alberta, Canada, the assignee of US Patent No. 7,803,385 directed to a modified reovirus for the treatment of cancer, finally received a Certificate of Correction from the US Patent and Trademark Office (USPTO) showing 122 days of patent term adjustment, a patent term adjustment originally and repeatedly denied by the USPTO.

Rosetta Stone v Google: AdWords Still Not Out of the Woods

Firm News, Trademark

In his recent article for World Trademark Review, Steve Schaetzel reports on the U.S. Court of Appeals for the Fourth Circuit and its reversal of a Virginia district court’s summary judgement ruling that Google’s use of trademarks in its AdWords program was not likely to cause confusion as a matter of law.